Merck KGaA - Company Profile
Powered by
All the data and insights you need on Merck KGaA in one report.
- Save hours of research time and resources with
our up-to-date Merck KGaA Strategy Report
- Understand Merck KGaA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreMerck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops, and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility; and develops liquid crystal mixtures, organic light-emitting diode (OLED) materials, cosmetic active ingredients, pigments for coatings, and high-tech materials. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments and end-to-end systems. The company serves healthcare, performance materials, and life sciences markets. It has a presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.
Merck KGaA premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Prescription Drugs: | - | - |
Oncology | Single-use Manufacturing | Apaisyl |
Neurology & Immunology | Sterile Filtration | Bion |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | New Products/Services | In April, the company launched the Aptegra CHO genetic stability assay, the first all-in-one, validated genetic stability assay. |
2024 | Corporate Changes/Expansions | In March, the company opened a new office in Riyadh, Saudi Arabia. |
2024 | Corporate Changes/Expansions | In March, the company expanded its M LabTM Collaboration Center in Shanghai. |
Competitor Comparison
Key Parameters | Merck KGaA | F. Hoffmann-La Roche Ltd | Bayer AG | Sanofi | Novartis AG |
---|---|---|---|---|---|
Headquarters | Germany | Switzerland | Germany | France | Switzerland |
City | Darmstadt | Basel | Leverkusen | Paris | Basel |
State/Province | Hessen | - | Nordrhein-Westfalen | Ile-de-France | - |
No. of Employees | 62,908 | 103,605 | 99,723 | 87,994 | 76,057 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Belen Garijo | Chief Executive Officer | Senior Management | 2021 | 64 |
Helene von Roeder | Chief Financial Officer | Senior Management | 2023 | 54 |
Matthias Heinzel | Chief Executive Officer - Life Science | Senior Management | 2021 | 56 |
Peter Guenter | Chief Executive Officer - Healthcare | Senior Management | 2021 | 62 |
Kai Beckmann | Chief Executive Officer - Electronics business | Senior Management | 2017 | 59 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer